Chikungunya Vaccine, Hemophilia B Gene Therapy Among 14 Products On Track For EU Approval

 
• By Vibha Sharma

The EU is on track to get its first vaccine for preventing the disease caused by chikungunya virus. Thirteen other products have also been recommended for pan-EU approval. 

World Health Day. Global Health Awareness Concept. Globe and Stethoscope on blue background.
The Chikungunya Vaccine was assessed under the EMA’s OPEN framework to promote global public health • Source: Shutterstock

More from Europe

More from Geography